JUDITH GARRETT: Open Payments
NPI 1104896703 · CAMILLUS, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$400 in 19 payments from 13 companies in 2025. Trend: 2023 $203 · 2024 $445 · 2025 $400
Food & beverage: $400
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $80 |
| Novo Nordisk Inc | 2 | $41 |
| Boston Scientific Corporation | 2 | $34 |
| Astellas Pharma US Inc | 1 | $33 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $33 |
| Merck Sharp & Dohme LLC | 2 | $32 |
| Corcept Therapeutics | 1 | $30 |
| Seqirus USA Inc | 1 | $23 |
| AstraZeneca Pharmaceuticals LP | 1 | $22 |
| Exact Sciences Corporation | 1 | $21 |
Products named: QULIPTA, WATCHMAN FLX, Veozah, JOURNAVX, GARDASIL 9, Korlym, Fluad, AIRSUPRA.
Industry payments across NY — which companies pay providers there.
